IBM shares are off .2% in Friday investing. They have gained 6.5% in excess of the past 3 months, while the Dow Jones Industrial Common
DJIA,
-.07%
has shed 3.%.

The Wall Street Journal noted in early 2021 that IBM was contemplating a sale of the Watson Wellness enterprise, and a report from Axios previously this year indicated that the firm was continue to interested in a deal.

Subscribe: Want intel on all the information shifting markets? Signal up for our day-to-day Need to Know publication.

The transaction is not shocking, according to UBS analyst David Vogt, because important IBM govt and Watson proponent John Kelly retired from the company at the conclusion of 2020.

“Moreover, we consider the current market has been anticipating ongoing little modifications to IBM’s portfolio to divest firms that do not neatly suit into its three new company segments,” he wrote in a notice to clients.

IBM sees the offer as a way to turn into “even extra concentrated on our platform-centered hybrid cloud and AI technique,” Tom Rosamilia, its senior vice president for IBM Application, said in a launch.

While the corporations didn’t disclose financial terms of the arrangement, Vogt doubted that it would materially impact IBM’s financials “given the probably constrained achievement of this device the earlier various many years.”

He famous that, with Watson Health and fitness, IBM done various acquisitions as it sought to disrupt the health care industry by combining locations like individual documents, health-related literature, and health care imaging, and making use of details analytics to the approach.

IBM is due to report fourth-quarter earnings on Jan. 24.